Comparison between presepsin and procalcitonin in early diagnosis of neonatal sepsis

References

• Shaha CK, Dey SK, Shabuj KH, et al. Neonatal sepsis – a review. Bangladesh J Child Health. 2012;36(2):82–89.
   Google Scholar
• Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence. 2014;5(1):170–178.
   PubMed Web of Science ®Google Scholar
• Kementerian Kesehatan RI. Profil kesehatan indonesia tahun 2014. Jakarta; 2015. p. 107–110.
   Google Scholar
• Gardner SL. Sepsis in the neonate. Crit Care Nurs Clin North Am. 2009;21(1):121–41, vii.
   PubMedGoogle Scholar
• Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl 2):ii33–ii40.
   PubMed Web of Science ®Google Scholar
• Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006–1015.
   PubMed Web of Science ®Google Scholar
• Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50(1):23–36.
   PubMed Web of Science ®Google Scholar
• Adib M, Bakhshiani Z, Navaei F, et al. Procalcitonin: a reliable marker for the diagnosis of neonatal sepsis. Iran J Basic Med Sci. 2012;15(2):777–782.
   PubMed Web of Science ®Google Scholar
• Park IH, Lee SH, Yu ST, et al. Serum procalcitonin as a diagnostic marker of neonatal sepsis. Korean J Pediatr. 2014;57(10):451–456.
   PubMedGoogle Scholar
• Zou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16–19.
   PubMedGoogle Scholar
• Wu J, Hu L, Zhang G, et al. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis. PLoS One. 2015;10(7):e0133057.
   PubMed Web of Science ®Google Scholar
• Hayashida K, Kondo Y, Hara Y, et al. Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis. BMJ Open. 2017;7(3):e014305.
   PubMed Web of Science ®Google Scholar
• Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med. 2007;33(6):1025–1032.
   PubMed Web of Science ®Google Scholar
• Topcuoglu S, Arslanbuga C, Gursoy T, et al. Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern-Fetal Neonat Med. 2016;29(11):1–6.
   Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Glodstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):99.
   Google Scholar
• Mitsubishi Chemical, Medience. Pathfast-presepsin. Tokyo; 2011.
   Google Scholar
• Elabscience Biotechnology, Corporation. Human procalcitonin ELISA kit. Guandong Science, Wuhan; 2015.
   Google Scholar
• Melvan JN, Bagby GJ, Welsh DA, et al. Neonatal sepsis and neutrophil insufficiencies. Int Rev Immunol. 2010;29(3):315–348.
   PubMed Web of Science ®Google Scholar
• Karambin M, Zarkesh M. Entrobacter, the most common pathogen of neonatal septicemia in Rasht, Iran. Iran J Pediatr. 2011;21(1):83–87.
   PubMed Web of Science ®Google Scholar
• Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21–47.
   PubMed Web of Science ®Google Scholar
• Aminullah A, Gatot D, Kosim MS, et al. Penatalaksanaan sepsis neonatorum. Indonesia: DKR Health Technology Assessment; 2007.
   Google Scholar
• Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764–769.
   PubMed Web of Science ®Google Scholar
• V Ramana K, BharatKumar Pinnelli V, Kandi S, et al. Presepsin: a novel and potential diagnostic biomarker for sepsis. AJMBR. 2014;2(4):97–100.
   Google Scholar
• Arai Y, Mizugishi K, Nonomura K, et al. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother. 2015;21(8):564–569.
   PubMed Web of Science ®Google Scholar
• Shirakawa K, Naitou K, Hirose J, et al. The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models. Crit Care. 2010;14:P19.
   Google Scholar
• Chaudhury A, Sachin Sumant GL, Jayaprada R, et al. Procalcitonin in sepsis and bacterial infections. JCSR. 2013;2(4):216–224.
   Google Scholar
• Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections – hope for hype? Swiss Med Wkly. 2009;139(23–24):318–326.
   PubMed Web of Science ®Google Scholar
• Hendrianingtyas, Banundari RH, Indranila KS, et al. Serum procalcitonin, CRP and presepsin in SIRS. Indones J Clin Pathol Med Lab. 2014;20(3):180–182.
   Google Scholar
• Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care. 2013;17(5):R244.
   PubMed Web of Science ®Google Scholar
• Kim H, Hur M, Moon HW, et al. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care. 2017;7(1):27.
   PubMed Web of Science ®Google Scholar
• Resch B, Hofer N, Müller W. Challenges in the diagnosis of sepsis of the neonate. InTech. 2012:234–236.
   Google Scholar
• Ohlin A. Aspect on early diagnosis of neonatal sepsis. (Orebro studies in medicine). Sweden: Orebro University; 2010.
   Google Scholar